News
Hosted on MSN26d
EC approves argenx’s efgartigimod alfa for CIDP treatmentThe European Commission (EC) has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat ... CIDP who have previously undergone corticosteroid or ...
Gammagard Liquid is a prescription infusion used to help protect against infection and treat certain rare conditions. Learn about dosage, side effects, and more.
A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.
The amount Medicare pays for IVIG can vary based on factors such as the condition it is treating and the treatment setting. Learn more.
The role of nurses in transitioning from intravenous immunoglobulin (IVIG) to subcutaneous therapy in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) has been described in a new ...
Finally, subcutaneous immunoglobulin (SCIG), an immunoglobulin treatment administered under the skin, is an alternative treatment you could consider.
Background and aim: Subcutaneous immunoglobulin (SCIg) has emerged as an alternative to intravenous administration for patients with primary (PID) and secondary immunodeficiencies (SID), offering ...
Also, there are advancements in delivery systems such as subcutaneous immunoglobulin (SCIG), complement IVIG therapies and cater to patient preferences. Apart from this, IVIG market should definitely ...
IVIG prophylaxis led to improvements in infection-free survival as well as progression free and overall survival in patients with multiple myeloma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results